Fem-prin
NDC Package 50332-0145-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Fem-prin is usesfor the temporary relief of minor aches, pain, and water weight gain due to mentrual cycle. Marketed by Hart Health, this product is identified by NDC 50332-0145 and is authorized under FDA application M.

Identification & Billing

NDC Package Code
50332-0145-4
Package Description
40 PACKET in 1 BOX / 2 TABLET, FILM COATED in 1 PACKET
Product Code
50332-0145
11-Digit Billing Format
50332014504
RxNorm Crosswalk
  • RxCUI: 1052637 - acetaminophen 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet
  • RxCUI: 1052637 - APAP 500 MG / pamabrom 25 MG / pyrilamine maleate 15 MG Oral Tablet

Clinical Specifications

Proprietary Name
Fem-prin
Dosage Form
-
Usage Information
Usesfor the temporary relief of minor aches, pain, and water weight gain due to mentrual cycle

Regulatory & Marketing

Labeler Name
Hart Health
FDA Application #
M
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-09-2023
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (50332-0145). Click a package code to view its specific billing and regulatory data.

50332-0145-7
100 PACKET in 1 BOX / 2 TABLET, FILM COATED in 1 PACKET

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50332-0145-4 identifies a specific commercial package of 40 packet in 1 box / 2 tablet, film coated in 1 packet of Fem-prin, labeled by Hart Health. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hart Health on January 09, 2023. The current certification is valid through December 31, 2025.

How is this Hart Health product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50332014504. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50332-0145-4
11-Digit CMS (5-4-2)
50332-0145-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.